The Missing Link: Health Outcomes, Harms, and Uncertainty

The subject now is the gap between a change in feeding behavior and a change in health. Breastfeeding-support trials can directly compare an added service with usual care and measure whether more participants are breastfeeding later. They much less often measure infant illness, maternal wellbeing, or adverse experiences in a way that can explain the full causal chain. Keeping those links separate lets readers acknowledge the potential value of support without attributing every benefit associated with breastfeeding to the support intervention itself.

What the support trials measured—and what they did not

Only a minority of the randomized evidence measured health outcomes. The report’s summary counts 19 studies involving 11,175 participants with some infant or maternal health measure, while its detailed-results section describes 18 studies involving 10,505 participants. That internal difference does not change the main conclusion that health outcomes were sparsely measured. Ten trials, involving 6,592 participants, reported infant outcomes. These included gastrointestinal illness, otitis media, respiratory-illness visits, general healthcare utilization, hospitalization, childhood illness, or other minor health outcomes. The results tended to favor the intervention group, but few differences were statistically distinct, and the findings were mixed across outcomes and studies.

The mixed pattern is easier to understand through the size and design of the evidence. Two studies reported gastrointestinal outcomes and did not agree. In one small peer-counseling trial, infants in usual care had more than twice the risk of experiencing at least one diarrheal episode during the first three months than infants in the intervention group. Another study found no meaningful difference in gastrointestinal-related emergency or outpatient visits at one year, even though mothers in the intervention group breastfed for longer. A single study reporting otitis media and respiratory visits found no statistically significant difference in the full sample. These results can coexist because they come from different settings, interventions, populations, follow-up periods, and outcome definitions.

Eight studies reported healthcare visits, hospital admissions, or more general infant illness outcomes. The direction often favored the intervention group, but the differences were not statistically significant in all studies. In some cases, the intervention included postpartum in-home nursing or broader family support. That extra care could reduce healthcare use independently of any change in breastfeeding. If a program combines feeding assistance with general nursing support, an infant-health difference cannot be assigned to breastfeeding messages alone.

Maternal outcomes were similarly limited. Nine trials involving 2,334 participants reported anxiety, depression, wellbeing, or related symptoms, usually through three to six months postpartum. Most reported better symptom scores among intervention participants, but few differences between groups were statistically distinct. Two trials involving 2,533 participants reported weight-related outcomes and found no differences between intervention and control groups. The absence of a clear average effect does not prove that support never affects a person’s wellbeing; it shows that these trials do not provide a strong, consistent estimate of such an effect.

This distinction matters because the evidence surrounding breastfeeding itself is broader than the evidence surrounding support.